Clinical Trial

Enhancing Nursing Students' Empathy and Learning in Parkinson's Disease Through High-Fidelity Simulation and Blended Learning

Completed
View on ClinicalTrials.gov →
Summary
The goal of this randomized controlled trial is to evaluate the effectiveness of a multimodal Parkinson's disease-focused intervention on empathy levels and perceived theoretical-practical learning in third-year undergraduate nursing students. The main questions it aims to answer are: * Will students receiving the multimodal intervention demonstrate significantly higher levels of clinical empathy compared to those receiving standard simulation-based workshops? * Will the intervention significantly improve awareness of Parkinson's disease (PD) quality of life and the internalisation of the patient's lived experience? Researchers will compare the experimental group, which receives a multimodal approach including blended learning and a simulated home environment, to a control group receiving standard simulation workshops on physiological aging to see if the multimodal strategy offers superior outcomes in clinical awareness and empathy development. Participants will: * Attend a two-hour initial theoretical session regarding neurodegenerative disorders and nursing care. * Complete digital blended-learning micro-capsules covering PD pathophysiology and authentic patient testimonials (Experimental Group only). * Engage in high-fidelity physical simulation using GERT® suits to perform activities of daily living (e.g., dressing, eating, and walking) within either a recreated domestic environment or a standard classroom setting. * Participate in a structured debriefing session focused on reflective analysis of the emotional and functional impact of Parkinson's symptoms. * Complete validated self-administered instruments during pretest and posttest phases to measure empathy, satisfaction, and perception of learning.
Trial Details
NCT Number NCT07503418
Lead Sponsor University of Cadiz
Conditions Parkinson Disease (PD)
Enrollment 84 participants
Start Date 2025-02-01
Primary Completion 2025-05-31 (estimated)
Study Completion 2025-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-31